ESAM reduces sensitivity to anti-HER2 therapy in HER2-positive breast cancer by activating the mTOR pathway
16 September 2026 at 08:00
Cell Death Discovery, Published online: 16 September 2026; doi:10.1038/s41420-026-03349-8
ESAM reduces sensitivity to anti-HER2 therapy in HER2-positive breast cancer by activating the mTOR pathway